Today’s AI Top Pick: IDN

7/17/2026 · Low Float Bullish Consensus Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured 4-hour model accuracy · IDN61%205 resolved forecasts · 30d window · verify →

View the live IDN price forecast →

Today's pick · Low Float Bullish Consensus Deep RotationIDNBUY NOW8.4 / 107/17/2026

IDN (Intellicheck) is the cleanest multi-timeframe bullish setup in this pool that isn't already extended. Every single timeframe forecast is positive: 1h +20.5/+23.8/+21.1%, 4h +19.5/+37.6/+49.4%, 1d +15.7/+50.1/+49.5%, 1wk +12.6/+7.1/+2.8%. That is textbook 'all four TFs pointing up' — the gold-standard alignment. Bullish_prob is 1.0 and analyst recom is 1.67 with a 100% targetUpsidePct. Crucially, IDN scores best on the anti-chasing rule: position_in_21bar_range_pct is 0% on 1h, 4h, 1d AND 1wk. Drawdown from the weekly high is -56.5%. RSI is 29.68 — deeply oversold. Contrast this with MORN and HURN, which also have strong fundamentals but are pinned at 100% of range on multiple timeframes with weekly forecasts either flat or negative (HURN weekly fc: -18/-15/-15). MORN's 1h and 4h forecasts are actually negative. Buying MORN/HURN today is chasing a breakout; buying IDN today is buying a washed-out name where the model expects mean-reversion higher. Fundamentals are supportive rather than pristine: PE 34.56 is elevated but fwdPe of 22.06 with epsNextY of 25.93% growth and salesYoY of 15.26% keeps it a real growth story. Gross margin 90.68% and debt/equity of 0 are excellent; ROE 11.38% and profitMargin 9.56% show it's actually profitable — rare for a $76M-cap. FundScore 5.75 is one of the higher scores in the group. Catalyst check is clean: Russell 2000/3000 inclusion effective late June and a recent CEO media appearance on AI fraud — both mild positives, no dilution filings, no guidance cuts, no short-seller reports. Compare to MBRX (-25% on failed trial data), IPWR ($75M shelf), TOYO (~$50M offering), PRSO ($25M Roth agreement), NXTC (all-stock merger with $320M PIPE) — all of which have material overhangs. The one real caveat on IDN is near_term_bullish of 0.2 (last few bars soft), but that's exactly what an oversold entry looks like. Waiting risks paying up after the forecast rerates.

IDN forecast chart
Entry zone
$3.60 – $3.75 (buy into current $3.69 print or a shallow dip to $3.60)
Stop loss
$3.30 (roughly -10%, below the recent 4h/1d structure low and past where the oversold thesis is broken)
First target
$4.30 (matches 1h/1d fc_short of ~+15-20%)
Longer target
$5.50 – $6.00 (aligns with 4h/1d fc_mid/long of +37-50%; also fills part of the -56% weekly drawdown)
Risks
  • Near-term bullish score is only 0.2 and 1wk recent_21bar_pct is -24% — the tape is still weak and the bounce may need another shakeout to $3.30-3.40 first
  • Micro-cap ($76M) with 6.3% short float — thin liquidity can cause slippage and gap risk
  • PE 34.56 / fwdPe 22.06 is not cheap; if the growth story (epsNextY 25.9%) disappoints on next earnings the multiple compresses fast
  • 1wk fc_long is only +2.79% — model does not see a full retrace of the -56.5% drawdown; this is a bounce trade, not a multi-quarter hold
  • All small-cap AI/ID-verification names have headline sensitivity — a competitor announcement or a soft quarter can undo the setup
Honorable mentions
MORNBest fundamentals in the pool (fundScore 8, PE 17.72, PEG 0.74, ROE 30.66%, profitMargin 16.06%) with bullish_prob 1 and near_term_bullish 1.0. Weekly fc +6.8/+28.2/+44.1 is excellent. Downgraded to #2 only because it's at 100% of range on 4h and 1d and the 1h/4h short-horizon forecasts are negative (-5 to -7%) — this is a BUY_PULLBACK, not a chase-here.
AMROversold coal/met name (RSI 32.46, -21.9% on 1d, position 12% of range) with bullish_prob 1, near_term_bullish 0.8 and all-positive forecasts across every TF (1wk +14.5/+26.2/+27.4). InstOwn 90.4%, salesYoY -19% and negative margins are the drag, and UBS just initiated Neutral. Solid alternative if you want a larger-cap oversold bounce.
Full ranking (29)
#SymbolVerdictScoreRead
1IDNBUY NOW8.4All 4 TFs positive, 0% of range, RSI 29.68, bullish_prob 1 — cleanest oversold-with-confirmation setup.
2MORNBUY PULLBACK8.0Best fundamentals (fundScore 8, PEG 0.74, ROE 30.7%) and 1wk fc +44%, but at 100% of range on 4h/1d — wait for a dip to $168-172.
3AMRBUY NOW7.4RSI 32, -21.9% recent, position 12%, all TFs positive with 1d fc_long +29.7% and bullish_prob 1.
4HURNBUY PULLBACK6.8Strong fundamentals (fundScore 7, recom 1.0, targetUpside 55%) but at 100% of 4h/1d range and weekly fc is negative -18/-15/-15%.
5EVGNBUY PULLBACK6.41d fc +63/+89/+83 and near_term_bullish 1.0, positive AI drug-discovery catalyst, but 1d position 100% — wait for pullback.
6TASKBUY PULLBACK6.2PE 5.26 / fwdPe 3.88 is cheap and 1d fc +36/+42/+39, but position 92% on 1d and 1h fc is -12%.
7AZOWAIT5.9Quality large-cap with fc_mid +20% on 1d, but 1wk fc -6/-11% and $50B cap makes this a low-conviction pick in a low-float lens.
8BCDABUY PULLBACK5.6Position 0% and fc_long +66% on 1d, near_term_bullish 1.0, but micro-cap $12.7M biotech with ROE -950%.
9QNTMWAIT5.41d fc +35/+83/+77 with near_term_bullish 1.0, but 1wk fc_short is -33.6% and weekly forecasts are unstable.
10BCGWAIT5.2Profitable financial micro-cap with 1d fc +12/+32/+35 and near_term_bullish 1.0, but 1wk fc_short -28.6% and no analyst coverage.
11PAPLWAIT5.01d fc +19/+42/+55 with near_term_bullish 1.0, but profitMargin -161% and fwdPe 49.3.
12GLMDWAIT4.8Positive cardiac-Aramchol catalyst and 1d fc +30/+113/+137, but 1wk fc of +1392% signals model outlier — unreliable magnitudes.
13NXTCAVOID4.6Just announced all-stock merger + $320M PIPE — thesis is now event-driven arb, not a clean forecast trade.
14LTRNWAIT4.51d position 0% with fc +8/+25/+22 and positive AI platform catalyst, but epsNextY -33.8% and ROE -157%.
15DRMAWAIT4.31d fc +22/+100/+167 but 1wk fc of +15193% is broken model output; $5M micro-cap.
16XTLBWAIT4.21d/1wk fc strong (+23/+43/+47 and +49/+73/+108) but 1h and 4h forecasts are negative.
17SEGGWAIT4.0Position 0% and 1d fc +46/+68/+72 with near_term_bullish 1.0, but Nasdaq reporting deficiency and profitMargin -3609%.
18MBRXAVOID3.7Stock dropped 25% on 6/30 as interim MIRACLE data missed significance — headline undercuts the forecast.
19DAREWAIT3.61wk fc +25/+52/+87 but 1d fc only +0.5/+10/+8, debtEq 9.84 and operMargin -1034%.
20RGNTWAIT3.5Positive EU regulatory approval catalyst and 1d fc +16/+52/+45, but bullish_prob is null and 1d position 0% with -54% recent.
21PRSOAVOID3.2Just signed a $25M ATM with Roth on 6/30 — dilution overhang directly undercuts the +290% 1wk fc_short.
22IPWRAVOID3.0Filed $75M mixed-shelf prospectus 7/10 — dilution risk swamps the forecast; profitMargin -44,730% is a red flag.
23TOYOAVOID2.8Great fundamentals (fundScore 8, PEG 0.03) but just did ~$50M raise 6/24 and expected_return_pct in the screen is -15.6%.
24CREAVOID2.7bullish_prob null, 1h fc is negative across all horizons, no analyst coverage, no target upside data.
25USBCAVOID2.51d fc is -22/-38/-11 (negative) and 1wk fc of +2231% is unreliable outlier; near_term_bullish 0.2.
26WWAVOID2.4Only 1d data available, debtEq 1.76, salesYoY -9.6%, bullish_prob is null.
27SSMAVOID2.2Only 1d timeframe available, operMargin -5643%, bullish_prob null — no multi-TF confirmation possible.
28VEEEAVOID2.01d recent_21bar +656.74% with position 100% of range — pure chase after a merger-driven parabolic move.
29AIMAVOID1.5bullish_prob 0.4, near_term_bullish 0, profitMargin -14,123%, and 1d fc_short is negative -28%.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.